Author

E. Mesri

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Research Focus:cancer & tumor microenvironment· 2 Research Focus:cell type annotation· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell-cell communication· 1 Research Focus:chromatin & epigenetic regulation· 1

Frequent Co-Authors

J. Naipauer· 3 shared M. Abba· 2 shared A. Ahuja· 1 shared A. Raimondi· 1 shared C. Premer· 1 shared D. Salyakina· 1 shared D. Sapochnik· 1 shared E. Lacunza· 1 shared

Activity by Year

2019-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

J. Naipauer

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Single-cell RNA sequencing identifies KSHV-infected Mesenchymal stem cell subpopulations precursors of Kaposi's Sarcoma

J. Naipauer, E. Lacunza, A. Ahuja, O. A. Coso, M. Abba, E. Mesri

The paper uses single-cell RNA sequencing to identify KSHV-infected hMSC subpopulations that exhibit features of KS progenitor cells through upregulated viral and host oncogenes in a pro-angiogenic environment.

bioRxiv · Feb 28, 2023 · PreprintMicrobiology

PDGFRA Defines the Mesenchymal Stem Cell Kaposi’s Sarcoma Progenitors by Enabling KSHV Oncogenesis in an Angiogenic Environment

J. Naipauer, S. Rosario, S. Gupta, C. Premer, O. Mendez, M. Schlesinger, V. Ponzinibbio, V. Jain, L. Gay, R. Renne, H. L. Chan, L. Morey, D. Salyakina, M. Abba, S. Williams, , E. Mesri

The paper identifies PDGFRA+ bone marrow-derived mesenchymal stem cells as Kaposi’s sarcoma progenitors and shows pro-angiogenic conditions enable KSHV oncogenesis through epigenetic de-repression.

bioRxiv · Oct 2, 2019Cancer Biology

A major Role for Nrf2 transcription factors in cell transformation by KSHV encoded oncogenes.

D. Sapochnik, A. Raimondi, V. Medina, J. Naipauer, E. Mesri, O. Coso

This study identifies Nrf2 transcription factors as key mediators of KSHV oncogene-induced cell transformation through the vGPCR-Ga13-RhoA signaling pathway and Erk1/2 MAPK activation.

bioRxiv · Jun 21, 2019 · PreprintCancer Biology